Study of Oral MRT-2359 in Selected Cancer Patients

Clinical trial NCT05546268 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05546268
Sponsor: Monte Rosa Therapeutics, Inc
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

NSCLC SCLC High Grade Neuroendocrine Cancer DLBCL L-MYC and N-MYC Amplified Solid Tumors NSCLC With High or Low L-MYC or N-MYC Expression HR-positive, HER2-negative Breast Cancer Prostate Cancer

Start date: 2022-10-12
Primary completion: 2026-05-01
Enrollment: 174

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.